In the last study published in LancetA group of researchers assessed safety, tolerance, pharmacokinetics and effects that reduce the weight of subcutaneous amicretin once a week in adults who are overweight or obesity. Background Obesity affects more than one billion people around the world. It drives serious conditions, such as cardiovascular diseases, type 2 diabetes […]